Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

15.0%

3 terminated/withdrawn out of 20 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

25%

5 trials in Phase 3/4

Results Transparency

40%

6 of 15 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

N/A

5(33.3%)

Phase 4

4(26.7%)

Phase 1

3(20.0%)

Early Phase 1

1(6.7%)

Phase 2

1(6.7%)

Phase 3

1(6.7%)

15Total

N/A(5)

Phase 4(4)

Phase 1(3)

Early Phase 1(1)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials

NCT00747396Not ApplicableActive Not Recruiting

The Bucharest Early Intervention Project

Role: collaborator

NCT02237079Phase 4Completed

Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)

Role: lead

NCT03109431Not ApplicableCompleted

Stepped Care for Youth Living With HIV

Role: collaborator

NCT03134833Not ApplicableCompleted

Engaging Seronegative Youth to Optimize HIV Prevention Continuum

Role: collaborator

NCT03459716Unknown

Endothelial Biomarkers of Systemic Sclerosis-associated Pulmonary Hypertension

Role: collaborator

NCT03643783Completed

Impact of Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic Patients

Role: collaborator

NCT00846872Phase 1Withdrawn

Effect of Continuous GHRP-3 Infusion at on GH-IGF-I System, Blood Pressure, Glucose, and Insulin Resistance

Role: lead

NCT00461331Phase 4Completed

Comparison of Insulins Aspart and Lispro in Insulin Pumps

Role: lead

NCT00323375Phase 1Completed

Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine

Role: lead

NCT00455494Phase 1Completed

Food-Effect Bioavailability Study of AQ-13, a Candidate Antimalarial

Role: lead

NCT01787656Completed

A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus

Role: collaborator

NCT01832480Phase 3Completed

Trichomonas Vaginalis Repeat Infections Among HIV Negative Women

Role: lead

NCT00609271Not ApplicableCompleted

Study of Macronutrients and Heart Disease Risk

Role: lead

NCT02152072Withdrawn

Using Simulation-Based Training to Incorporate Lung Ultrasound Into Physical Examination

Role: lead

NCT00993642Early Phase 1Withdrawn

ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer

Role: lead

NCT01018095Phase 4Completed

Trichomonas Vaginalis Recurrence Among HIV+ Women

Role: lead

NCT01874158Completed

DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women

Role: lead

NCT01579617Not ApplicableCompleted

e-SiHLE: An Internet Pregnancy Prevention for Older Teenage Girls

Role: lead

NCT00726713Phase 4Completed

Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)

Role: collaborator

NCT00028860Phase 2Completed

Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer

Role: lead

All 20 trials loaded